Redstone Research was formed by individual, independent consultants that recognized the need for organized efforts on clinical development teams. Our team consists of individuals located throughout the United States who have successfully worked together on previous projects. Collectively, our long-lasting working relationships with investigative sites are utilized for the success of an entire clinical trial. We are a small Clinical Research Consulting company with a large scope of services and trial management experience. Each member of our team enhances the services and efforts highlighted in our mission. Through years of experience and a valued interest in clinical trial research, the Redstone team proves to be a solid choice in conducting your trials.
Robert O. Kerr M.D.
Dr. Robert Kerr has been involved in laboratory and clinical research for more than twenty-five years and has been invited to present the results of his research in both the United States and Europe. He is the author of numerous publications and has served as president of the Texas Division of the American Cancer Society, president of the Texas Society of Medical Oncology, and chief of medical staff at two hospitals in Austin, TX. Additionally, he has served as chairman and member of several state and national committees. Dr. Kerr is a regular presenter of Oncology CME. He is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the European Society of Medical Oncology. He is board certified in Internal Medicine and Hematology. More recently, Dr. Kerr has served on the review board of 2 IRBs reviewing over 150 investigative plans. Prior to dedicating his time to support pharmaceutical IND applications, Dr. Kerr founded and practiced oncology at Southwest Regional Cancer Center.
Robert Kerr is a Magna Cum Laude graduate of Elizabethtown College, and an AΩA graduate from University of Pittsburgh School of Medicine. After completing an internship and residency in Internal Medicine at the University of Pittsburgh Hospitals, he completed an oncology fellowship at the University of Minnesota. Dr. Kerr has held faculty positions at the University of Minnesota and the University of Texas- San Antonio.
A. Lelo Diaz
Lelo Diaz has been working on pharmaceutical and medical device developments since 2001. He was first introduced to the industry while he was a medical student at the University of Texas Medical School in Galveston. That was the start of what led to a variety of roles in the Clinical Operations of pharmaceutical and medical device companies. He started Redstone Research to better provide clinical operation services to a more diverse research market and continues to work in support of Sponsor IND/IDE applications.
Prior to medical school, Mr. Diaz conducted preclinical research through the Biomedical Research Training Program at the University of Texas at Austin. Though focused on Oncology, and Cardiovascular diseases, Mr. Diaz has successfully driven a large variety of therapeutics to market.
Lelo Diaz has a Bachelor of Science in Biology from Southern Methodist University. He is a member of the Drug Information Association, the Association of Clinical Research Professionals, BioAustin, Associate Member of the American Society of Clinical Oncology, and served as a Board Member for the Environmental Healthcare Foundation.